http://ipkitten.blogspot.com/2023/11/referral-on-description-amendments.html
We have moved one step closer to a referral to the Enlarged Board of Appeal on description amendments. As previously reported, in appeal case T 56/21 the Board of Appeal invited the applicant (Roche) to request a referral to the EBA on the question of compulsory adaptation of the description in line with the claims. The applicant has subsequently submitted their request for a referral. We now await final confirmation from the Board of Appeal.
Amending the description: Why do we care?
Amending the description |
The controversy over description amendments began with a substantial tightening in the 2021 EPO Guidelines for Examination. The Guidelines currently require that, when amending or adapting the description in line with the claims, the applicant must either delete subject matter not covered by the claims, or explicitly state in the description that such subject matter is not part of the invention (F-IV, 4.3). The EPO position is that the description “shall be used to interpret the claims” (Article 69 EPC) and so the claims can only clearly define the invention (Article 84 EPC) if they are not contradicted by the description. If there is a contradiction between the claims and the description, it is argued, the scope of the invention will be unclear.
However, amending the description is a risky business for patentees and applicants. To begin with, description amendments may add matter and lead to the inescapable added matter trap post-grant (IPKat). Additionally, amendments to the description may adversely impact claim interpretation post-grant in both invalidity and infringement proceedings (IPKat).
The EPO is the only major patent office that requires strict adaptation of the description in line with the claims. The EPO’s approach to adaptation of the description is also curious in view of its general approach to claim interpretation. Unlike the UK courts, there is considerable Board of Appeal case law supporting an approach to claim interpretation that does not require reference to the description (IPKat). Particularly, the Boards of Appeal can be perfectly happy to ignore contradictory language in the description for the purposes of claim construction. According to a number of recent Board of Appeal decisions, if the language of the claims is clear per se, then the description can be ignored. However, if the description is to be ignored in cases of contradictory meanings between the description and the claims, why then is it necessary to amend the description? (IPKat).
A hint as to why EPO is so bullish on the issue of adaptation of the description was provided at the recent CIPA Congress 2023. At CIPA Congress this year, Steve Rowan (EPO Vice-President) spoke about the EPO’s current focus on patent quality. Mr Rowan emphasised that it is down to both the patent office and applicants to ensure the continued quality of granted European patents. This included, for example, ensuring conformity between the claims and the description of granted EP patents.
Roche shoulders the burden
Despite the disharmony on the issue among the Boards of Appeal it has never been clear that we would get a referral on description amendments. The risks of amending the description before grant of a patent can be mitigated (albeit expensively) by filing a divisional application, so as to at least keep an application pending should the granted patent fall down for added matter. The down-stream consequences of description amendments on claim interpretation may also only become clear years after grant. The Board of Appeal in the case in question noted that a referral to the EBA would delay grant, and therefore left it to the applicant to decide.
The applicant, Roche, has now submitted their response requesting the referral. Roche also suggests some clarifying amendments to the question proposed by the Board of Appeal. Roche’s proposed questions are as follows:
1. Is there a lack of clarity of the claims or a lack of support of the claims by the description within the meaning of Article 84 EPC if a part of the disclosure of the invention in the description and/or drawings in the specification (e.g. an embodiment of the invention, an example or a claim-like clause) is not encompassed by the subject-matter for which protection is sought as defined in the claims (“inconsistency in scope between the description and/or drawings and the claims”)?
2. If the answer to question 1 is “yes”, can an application consequently be refused based on Article 84 EPC if the applicant does not remove the inconsistency in scope between the description and/or drawings and the claims by way of amendment of the description (“adaptation of the description”).
Roche also submits that the referral should relate to adaptation of the description in all forms of proceedings, i.e. including opposition proceedings.
In support of their referral request, Roche identifies conflicting case law on the issue of description amendments. T 1989/18 (IPKat, Board 3.3.04, same applicant and Board as T 56/21), T1444/20 (IPKat, Board 3.3.01) and T 2194/19 (IPKat, Board 3.5.03) all found a lack of legal basis for the requirement for the description to be amended in line with the claims. T 3097/19 (IPKat, Board 3.5.06) on the other hand, disagreed with these decisions and found that the requirement for the description to be amended in line with the claims does have legal basis.
Roche also argued that it was difficult to reconcile the practice of the EPO with the case law on clarity requiring the claims to be clear in themselves without the need to refer to the description for interpretation (IPKat). Finally, Roche further attached a resolution from FICPI (the International Federation of Intellectual Property Attorneys), which outlines the danger and burden to applicants of the EPO’s description amendment requirement.
Final thoughts
The mere fact of a referral to the EBA does not of course mean that we would then necessarily receive clarity on the issue of description amendments. The EBA does have a habit of rephrasing the questions referred to it in order to avoid issues of general application beyond the facts of the case at hand (G 1/21, IPKat) or of providing self-confessedly vague advice even when it does answer the question (G2/21, IPKat). Even if the EBA were to give a clear answer on description amendments, the answer it gives may not be to everyone’s liking. The EBA may find in favour of the requirement, or even reason itself into adopting an stricter approach that would then have to be applied by the Boards of Appeal. A case of being careful what you wish for?
Further reading
Claim interpretation
- Boeing’s comma drama: Commas and taking the description into account when construing a claim (T 1127/16) (April 2021)
- Another case of catastrophic comma loss (T 1473/19): Interpreting the claims in view of the description (Jan 2023)
- EPO tries to have its cake and eat it on claim interpretation (T 0169/20) (March 2023)
- Construing the claims to include technical effects mentioned in the description (T 1924/20) (April 2023)
- The risk of pre-grant description amendments (T 450/20) (July 2023)
- Benefits and pitfalls of functional patent claims (and why the UK is out of step with the EPO on claim construction): Astellas v Teva [2023] EWHC 2571 (Pat) (Nov 2023)
Description amendments
- Board of Appeal finds no legal basis for the requirement to amend the description in line with the claims (T1989/18) (Dec 2021)
- Can amending the description to summarize the prior art add matter to the patent application as filed? (T 0471/20) (Jan 2022)
- EPO Board of Appeal toes the party-line on description amendments (T 1024/18) (April 2022)
- Board of Appeal case law against the description amendment requirement starts to mount up (T 2194/19) (16 Nov 2022)
- Another Board of Appeal enters the fray on description amendments (T 3097/19) (Nov 2022)
- Board of Appeal poised on the brink of a referral on description amendments (T 56/21) (July 2023)
- Adding matter by amending the description to exclude embodiments (Ensygnia v Shell [2023] EWHC 1495 (Pat) (Aug 2023)
Content reproduced from The IPKat as permitted under the Creative Commons Licence (UK).